|
⚲
|
| Keyboard |
| Collins Helen Louise
✚
|
|
|---|---|
| CIK # | 0001701247 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001701247] | |
| 4 | [0001701247] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Enliven Therapeutics Inc | |
| Collins Helen Louise | |
| Zeta Acquisition Corp III | |
| IO Biotech Inc | |
| Five Prime Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
|
2026-03-25 | Option exercise | 40,000 | $0.00 | |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2026-03-25 | Option exercise | 40,000 | $2.48 | 99,200 |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2026-03-25 | Sell | 40,000 | $35.10 | 1,404,000 |
|
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
|
2026-03-17 | Option exercise | 5,000 | $0.00 | |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2026-03-17 | Sell | 5,000 | $27.76 | 138,800 |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2026-03-17 | Option exercise | 5,000 | $2.48 | 12,400 |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2026-03-10 | Option exercise | 10,129 | $2.48 | 25,120 |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2026-03-10 | Sell | 10,129 | $30.19 | 305,795 |
|
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
|
2026-03-10 | Option exercise | 10,129 | $0.00 | |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2026-03-09 | Sell | 29,871 | $30.02 | 896,727 |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2026-03-09 | Option exercise | 29,871 | $2.48 | 74,080 |
|
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
|
2026-03-09 | Option exercise | 29,871 | $0.00 | |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2026-02-17 | Sell | 45,000 | $26.17 | 1,177,650 |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2026-02-17 | Option exercise | 45,000 | $2.48 | 111,600 |
|
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
|
2026-02-17 | Option exercise | 45,000 | $0.00 | |
|
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
|
2026-02-12 | Grant | 150,000 | $0.00 | |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2026-02-12 | Grant | 25,000 | $0.00 | |
|
Zeta Acquisition Corp III KURA
Option to purchase common stock · derivative
|
2025-06-05 | Grant | 28,500 | $0.00 | |
|
IO Biotech Inc IOBT
Stock Option (Right to Buy) · derivative
|
2025-06-05 | Grant | 35,144 | $0.00 | |
|
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
|
2025-02-06 | Grant | 171,000 | $0.00 | |
| showing 20 of 84 most recent transactions | |||||